Medifast, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $109.1M | $81.4M |
| FY2019 | — | $104.8M | $77.0M |
| FY2020 | — | $157.2M | $163.7M |
| FY2021 | — | $202.5M | $104.2M |
| FY2022 | — | $155.0M | $87.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $109.1M | $81.4M |
| FY2019 | — | $104.8M | $77.0M |
| FY2020 | — | $157.2M | $163.7M |
| FY2021 | — | $202.5M | $104.2M |
| FY2022 | — | $155.0M | $87.7M |